The effect of 3'-azido-3'-deoxythymidine (AZT) on in vitro infection of peripheral blood mononuclear cells (PBMCs) isolated from normal adult individuals with human T cell leukaemia/lymphoma virus type I (HTLV-I) was evaluated. Different PBMC samples were exposed to HTLV-I by cocultivation with MT-2 (a chronically infected cell line) in the presence of 20 U/ml of human recombinant interleukin 2 (IL-2) and graded concentrations of AZT. Control and drug-treated cultures, of both infected and uninfected PBMCs, were then grown for several weeks and monitored for virological and immunological parameters. The results showed a concentration-dependent anti-proliferative effect of AZT in both infected and non-infected cultures. Production of both proviral DNA and viral RNA was inhibited not only at the higher concentrations of AZT (8 mu M and 32 mu M) but also at concentrations as low as 0.1-2 mu M. These results were confirmed by PCR and by Row cytometry analysis for the viral core protein pig. Moreover, treatment with AZT resulted in a decreased expression of CD25 in cultures exposed to HTLV-I as well as in non-infected PBMCs. On the other hand, HLA-DR was down-regulated to a greater extent in drug-treated, virus-exposed cultures in comparison with those not infected. No evidence of the antiviral activity of AZT was observed in PBMC cultures already infected by HTLV-I or in MT-2 cells. These findings demonstrate that treatment with AZT, when given at the time of infection with HTLV-I, has a marked protective effect on PBMCs.

Macchi, B., Faraoni, I., Zhang, J., Grelli, S., Favalli, C., Mastino, A., et al. (1997). AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. JOURNAL OF GENERAL VIROLOGY, 78(5), 1007-1016 [10.1099/0022-1317-78-5-1007].

AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro

MACCHI, BEATRICE;FARAONI, ISABELLA;GRELLI, SANDRO;FAVALLI, CARTESIO;
1997-01-01

Abstract

The effect of 3'-azido-3'-deoxythymidine (AZT) on in vitro infection of peripheral blood mononuclear cells (PBMCs) isolated from normal adult individuals with human T cell leukaemia/lymphoma virus type I (HTLV-I) was evaluated. Different PBMC samples were exposed to HTLV-I by cocultivation with MT-2 (a chronically infected cell line) in the presence of 20 U/ml of human recombinant interleukin 2 (IL-2) and graded concentrations of AZT. Control and drug-treated cultures, of both infected and uninfected PBMCs, were then grown for several weeks and monitored for virological and immunological parameters. The results showed a concentration-dependent anti-proliferative effect of AZT in both infected and non-infected cultures. Production of both proviral DNA and viral RNA was inhibited not only at the higher concentrations of AZT (8 mu M and 32 mu M) but also at concentrations as low as 0.1-2 mu M. These results were confirmed by PCR and by Row cytometry analysis for the viral core protein pig. Moreover, treatment with AZT resulted in a decreased expression of CD25 in cultures exposed to HTLV-I as well as in non-infected PBMCs. On the other hand, HLA-DR was down-regulated to a greater extent in drug-treated, virus-exposed cultures in comparison with those not infected. No evidence of the antiviral activity of AZT was observed in PBMC cultures already infected by HTLV-I or in MT-2 cells. These findings demonstrate that treatment with AZT, when given at the time of infection with HTLV-I, has a marked protective effect on PBMCs.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/14
Settore MED/07 - Microbiologia e Microbiologia Clinica
English
Con Impact Factor ISI
LEUKEMIA-VIRUS; HTLV-I; INTERFERON-ALFA; CORD-BLOOD; INFECTION; EXPRESSION; ZIDOVUDINE; TRANSFUSION; RESISTANCE; MECHANISMS
Macchi, B., Faraoni, I., Zhang, J., Grelli, S., Favalli, C., Mastino, A., et al. (1997). AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. JOURNAL OF GENERAL VIROLOGY, 78(5), 1007-1016 [10.1099/0022-1317-78-5-1007].
Macchi, B; Faraoni, I; Zhang, J; Grelli, S; Favalli, C; Mastino, A; Bonmassar, E
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Jgenvirol1997.pdf

accesso solo dalla rete interna

Descrizione: articolo principale
Licenza: Copyright dell'editore
Dimensione 939.5 kB
Formato Adobe PDF
939.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/49576
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 60
  • ???jsp.display-item.citation.isi??? 58
social impact